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Bacterial pneumonia remains a leading cause of 
death in humans, especially when complicated 
with bacteremia and sepsis. Conversely, sepsis 
resulting from primary infection at other sites is 
often complicated by the development of acute 
respiratory distress syndrome, and in fact, sepsis 
accounts for as many as half of all cases of acute 
respiratory distress syndrome (1–3). Lung injury 
often occurs at the onset of bacteremia, result-
ing in the failure of this organ. In both bacterial 
pneumonia and acute lung injury secondary to 
bacteremia, pathophysiological changes include 
compromise of the alveolar-capillary barrier 
which results in edema and consequently intra-
vascular shunting and poor ventilation of the 
alveolus. Studies of sterile acute respiratory dis-
tress in dogs over 15 years ago suggested that 
the loop diuretic furosemide could decrease the 
intravascular shunt and improve pulmonary ox-
ygen exchange (4). Clinical studies also suggested 
that this loop diuretic could improve pulmo-
nary function of premature infants with chronic 
lung disease (5).
Loop diuretics such as furosemide and bu-
metanide block the activity of the two isoforms 
of the Na+-K+-2Cl− transporter, NKCC1 and 
NKCC2. Na+-K+-2Cl− cotransporters couple 
the electroneutral cellular uptake of one mole-
cule of both Na+ and K+ with two molecules 
of Cl− across the cell membrane. Under normal 
physiological conditions, NKCC cotransporters 
mediate a net infl  ux of ions into cells because 
of the inwardly directed chemical gradients 
for Na+ and Cl− ions (6, 7). These systems are 
present in a broad spectrum of eukaryotic cells 
and are believed to play a central role in vecto-
rial salt transport across epithelia and volume 
regulation in epithelial and nonepithelial cells 
(8, 9). Molecular studies have identifi  ed two 
isoforms, NKCC1 and NKCC2, that share 
 60% identity (10–12). NKCC2 (Slc12a1) en-
codes a cotransporter expressed almost exclu-
sively in the kidney, where it is found in the 
cells of the ascending loop of Henle (13–15). 
Here it plays a critical role in the vectorial trans-
port of ions (Na+, K+, and Cl−) from the glo-
merular ultra fi  ltrate and hence is often referred 
to as the absorptive cotransporter. The fact that 
the improvement of the development of an 
intrapulmonary shunt after induction of acute 
lung injury was observed in dogs in which the 
kidneys had been surgically removed suggested 
that the benefi  cial eff  ects of furosemide were not 
the result of blocking of this cotransporter (4). 
Similarly, in the premature infant, the improve-
ment in gas exchange was more pronounced 
when furosemide was delivered as an aerosol, 
conditions under which the diuretic eff  ects of this 
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agent were limited (5). Thus, both of these studies suggested 
that the benefi  cial eff  ects of furosemide in models and patients 
with acute lung injury were the result of inhibition of the sec-
ond transporter NKCC1.
The expression pattern of the NKCC1 gene (Slc12a2) dif-
fers markedly from that of NKCC2 (16–18). NKCC1 is also 
expressed at high levels in the kidney, where in contrast to 
NKCC2, its expression is restricted to the medullary collect-
ing duct and the glomerulus (15). Unlike NKCC2, the ex-
pression of NKCC1 is not limited to the kidney. NKCC1 is 
often referred to as the secretory cotransporter, because its 
expression is high in fl  uid-producing epithelia including the 
intestinal tract, salivary glands, submucosal glands, and the 
airway epithelia. However, pharmacological studies have identi-
fi  ed furosemide-sensitive cotransporter activity in many cell 
types including hematopoietic cells, and airway and vascular 
smooth muscle. NKCC1 is believed to contribute to the reg-
ulation of cell volume in these nonepithelial cells (19). Of 
particular interest is the potential contribution of this trans-
porter to the physiology of the endothelial cells, as they play 
a central role in many aspects of pneumonia and sepsis (20). 
Several studies suggest that NKCC1 regulates volume changes 
in these cells and that expression of NKCC1 by endothelial 
cells of the blood-brain barrier contributes to edema forma-
tion (21). It is therefore possible that similar expression of 
NKCC1 by lung endothelial cells can modulate the changes 
in microvascular permeability and thereby alter the course of 
infl  ammatory responses.
Mice lacking NKCC1 expression have been generated by 
several groups (22–26). The most readily observable pheno-
types of the NKCC1−/− mice are their loss of hearing and 
inner ear function and male infertility. In addition, survival of 
the mice is limited on most genetic backgrounds, and gener-
ally those animals that do survive are considerably smaller in 
size. Most studies to date have been performed using mice of 
mixed genetic background. This has limited the use of these 
animals to study the role of NKCC1 during infl  ammatory 
responses, as the majority of these responses are sensitive to 
modifi  er genes (27, 28).
To circumvent this problem, in this study we generate 
congenic F1 NKCC1−/− mice and control littermates. We 
examine both the infl  ammatory response and the development 
Figure 1.  Infl  ammatory cells and cytokines present in BALF 48 h 
after infection with K. pneumoniae. (A) Total number of cells present 
in the airways and thus recovered by BAL was higher in the lungs of 
NKCC1−/− mice (n = 30) than NKCC1+/+ mice (n = 29). (B) Cells present 
in the BAL were stained and identifi  ed based on morphological criteria. 
There was a statistically signifi  cant difference in the number of neutro-
phils in NKCC1−/− mice compared with wild-type controls. Macrophages 
remained unchanged in both groups. TNF-α, IL-1β, IL-10, and IL-6 levels 
were determined in the lung homogenates by ELISA kits. NKCC1−/− mice 
exhibited increased levels of (C) TNF-α and (D) IL-1β, but the increased 
levels did not reach statistical signifi  cance compared with littermate controls. 
(E) IL-10 levels were signifi  cantly reduced in NKCC1−/− mice compared with 
NKCC1+/+ mice. (F) IL-6 levels were also reduced in NKCC1−/− mice in 
comparison to NKCC1+/+ mice, but the reduced levels were not signifi  cant. 
Data are expressed as mean ± SEM; n = 7–10 mice per group for cytokine 
assays. *, P < 0.05; **, P < 0.005. conc., concentration.JEM VOL. 204, June 11, 2007  1385
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of bacteremia and sepsis after lung infections with Klebsiella 
pneumoniae in these animals. We show that lack of the co-
transporter reduces lung bacterial burden and dramatically 
reduces bacteremia and sepsis, which develops secondarily to 
this bacterial pneumonia.
RESULTS
Infl  ammation in NKCC1 mice after infection 
with K. pneumoniae
NKCC1−/− mice and littermate genetic controls were used 
to study the impact of loss of the cotransporter on the ability 
of the mice to mount a response to bacterial infection. In all 
cases, the mice were congenic F1 animals generated by the 
intercross of 129/SvEv+/− female animals with C57BL/6+/− 
males. Mice were infected with K. pneumoniae, and the de-
velopment of disease was assessed 48 h later (Fig. 1). Mice 
were killed and the cells present in the airways were collected 
by bronchoalveolar lavage (BAL). As expected, the bacterial 
infection resulted in a dramatic increase in the number of 
cells present in the BAL fl  uid (BALF). However, the number 
of cells present in the BALF collected from NKCC1−/− 
  animals was signifi  cantly higher (P = 0.002) than that collected 
from the normal littermates. Cells present in the BAL were 
stained and identifi  ed based on morphological criteria. As 
  expected, the majority of the cells recovered were neutrophils, 
and this population was signifi  cantly increased (P = 0.003) 
in the NKCC1−/− mice.
We also examined the production of cytokines in the 
lung after infection with K. pneumoniae. Total lung homoge-
nates were prepared from the lung 48 h after infection. As 
can be seen in Fig. 1, C–F, no diff  erences were observed in 
the levels of TNF-α or IL-1β. However, a small but signifi  -
cant decrease (P = 0.004) in the level of IL-10 was observed 
in the NKCC1−/− mice. Overall, the levels of cytokines 
measured in the lungs of the NKCC1−/− and wild-type mice 
were remarkably similar given the diff  erence in numbers of 
infl  ammatory cells in the airways.
To determine the impact of this diff  erence in the number 
of neutrophils present in the airways on the progression of the 
infectious response in the mice, a second set of experiments 
was performed. Again the mice were infected with 4 × 104 
bacteria. After 48 h mice were killed, blood was collected by 
heart stick, the lungs were collected and homogenized and 
CFUs in both samples were determined (Fig. 2). High levels 
of bacteria were detected in the blood of the wild-type mice. 
In contrast, loss of NKCC1 provided profound protection 
from the development of bacteremia with an almost 10-fold 
decrease in CFUs. This protection corresponded to decreased 
bacterial count in the homogenates prepared from the lungs 
of the NKCC1−/− animals compared with those prepared from 
wild-type mice. However, the diff  erence in lung burden was 
not as dramatic as the diff  erence observed upon comparison 
of CFUs present in the blood.
As expected, the high bacterial load and particularly the 
development of bacteremia corresponded with a marked 
hypothermia in the wild-type mice (Fig. 2 C). By 48 h, the 
profound drop in core temperature and the overall morbidity 
of the mice required that all animals in this group be killed. 
In comparison, the temperature of the NKCC1−/− mice 
remained well above 30°C, and the mice remained active 
throughout the time course of the experiment, consistent 
with the lower bacterial burden and the failure of the majority 
of these animals to develop substantial bacteremia.
Figure 2.  Colonization of the lung, bacteremia, and hypothermic 
sepsis after intertracheal infection of NKCC1−/− and control animals 
with K. pneumoniae. (A) Bacterial CFUs in the blood and (B) lung 
  homogenates of NKCC1−/− mice (n = 7–8) were signifi  cantly lower than 
NKCC1+/+ mice (n = 10–14). (C) Core temperatures of NKCC1−/− and 
wild-type littermates were determined before K. pneumoniae infection 
and 24 and 48 h thereafter. No differences were observed between the 
groups before inoculation or 24 h postinfection. However, the tempera-
ture drop observed in NKCC1−/− mice was signifi  cantly less than that 
measured for the NKCC1+/+ mice 48 h postinfection. Values are 
shown as mean ± SEM; n = 38–43 mice per group. *, P < 0.05; 
**, P < 0.000005.1386  PROTECTION OF NKCC− − MICE FROM SEPSIS | Nguyen et al.
Bactericidal activity of NKCC1−/− and wild-type neutrophils
A role for ion transport in the development and function of 
the mature phagosome has been noted by others (29). We 
therefore reasoned that the diff  erence in bacterial load and 
bacteremia could simply refl  ect  diff   erences in neutrophil 
function, specifi  cally killing of K. pneumoniae by the phago-
cytes. To address this possibility, neutrophils were prepared 
from bone marrow of NKCC1−/− and control animals and 
cocultured with K. pneumoniae. To facilitate phagocytosis of 
the K. pneumoniae, the bacteria was treated with serum prepared 
from mice, which had been previously immunized with killed 
K. pneumoniae. As can be seen in Fig. 3 A, and as expected, 
the number of CFUs recovered from cultures containing 
neutrophils was signifi  cantly reduced compared with those 
cultures containing only bacteria, and this recovery decreased 
over the 1-h incubation period. However, no diff  erence was 
observed between the ability of the NKCC1−/− and the 
wild-type neutrophils to eliminate the bacteria. Phagocytosis 
is normally accompanied by a dramatic increase in cellular 
oxygen metabolism. This “respiratory burst” results in the 
production of toxic reactive oxygen species essential for nor-
mal microbicidal activity of neutrophils. Neutrophils were 
isolated from the bone marrow of NKCC1−/− and control 
animals, and the production of superoxide in response to 
stimulation by PMA was determined. No diff  erence was 
noted between the production of this reactive oxygen species 
by the two diff  erent populations of neutrophils (Fig. 3 B). 
These fi  ndings are consistent with the inability to detect 
measurable amounts of NKCC1 mRNA in the neutrophil 
by RT-PCR (Fig. 4).
NKCC1−/− mice are not protected from K. pneumoniae–
induced peritonitis
To determine if loss of NKCC1 generally attenuated bacte-
rial growth and development of bacteremia and sepsis, we 
examined the consequence of K. pneumoniae–induced perito-
nitis in these animals and their littermate controls. Animals 
received an i.p. injection of 106 bacteria. To allow assessment 
of changes in vascular permeability resulting from challenge 
with this infectious agent, mice also received an i.v. injection 
of Evan’s blue. This dye binds to serum proteins and thus 
provides a method of quantitation of extravasation of pro-
teins from the circulatory system into the interstitial spaces 
and into the peritoneal cavity. 1 h later mice were killed, the 
peritoneal cavity was lavaged, and the number of CFUs 
present in the lavage fl  uid was determined. As can be seen in 
Fig. 5, in contrast to our fi  ndings in the lung, the bacterial 
burden of the NKCC1−/− mice did not diff  er signifi  cantly 
from that of the controls. Fewer leukocytes were present in 
the peritoneal cavity of the NKCC1−/− mice (Fig. 5 B). This 
did not, however, refl  ect a change in neutrophil recruitment 
but rather a change in the number of recovered macrophages 
(Fig. 5 C). Overall, the attenuated response noted in the 
NKCC1−/− mice in the bacterial pneumonia model was not 
apparent, at least at this time point, in the peritonitis model. 
Consistent with the decreased number of peritoneal leuko-
cytes, the level of serum proteins present in the peritoneal 
  lavage, as assessed  by measuring Evan’s blue levels, decreased 
in the NKCC1−/− animals (Fig. 5 D).
Sterile model of acute infl  ammation
We next determined whether similar diff  erences  between     
NKCC1−/− and wild-type mice in the infl  ux of cells in re-
sponse to infl  ammatory stimuli in the lung could be observed 
in a sterile model of infl  ammation (Fig. 6). NKCC1−/− and 
control mice received a single intratracheal bolus of LPS. 6 h 
later, the mice were killed, and the cells in the airways were 
collected and enumerated. As expected, LPS exposure re-
sulted in a rapid increase in airway leukocytes, and this was 
Figure 3.  Oxidative burst and killing of K. pneumoniae by 
NKCC1+ + and NKCC1−/− neutrophils. (A) After 0, 30, and 60 min of 
incubation with K. pneumoniae, neutrophils isolated from the bone 
  marrow of mice lacking NKCC1 did not differ from wild-type neutrophils 
in their ability to kill K. pneumoniae ex vivo. (B) Similarly, no difference 
was observed in superoxide production elicited by stimulation of the 
NKCC1−/− and NKCC1+/+ neutrophils with PMA. Results are shown as 
mean ± SEM; n = 5 mice per group.
Figure 4.  NKCC1 mRNA levels in lung and infl  ammatory cells. 
NKCC1 mRNA expression levels are signifi  cantly higher in the lung, an 
endothelial cell line (EOMA cell line, hemangioendothelioma origin, 
American Type Culture Collection no. CRL-2586), and primary lung endothe-
lial cells (Primary Endo) relative to expression levels of zymosan-elicited 
  neutrophils (Zym Neutrophils), bone marrow neutrophils (BM Neutrophils), 
BM mast cells (BMMC), and alveolar macrophages (Aveolar Mac). Data are 
expressed as mean ± SEM; n = 5 mice per group. *, ≠, δ, P < 0.01 relative 
to alveolar macrophage mRNA. Statistical analysis was performed using 
one-way ANOVA with Tukey’s Multiple Comparisons posttest.JEM VOL. 204, June 11, 2007  1387
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largely attributable to the recruitment of neutrophils. Again 
the number of cells recovered from the NKCC1−/− airways 
was substantially greater than the number recovered from the 
wild-type mice. A signifi  cant increase in both the number 
of neutrophils (P = 0.0001) and the number of macrophages 
(P = 0.004) was observed in the mutant animals (Fig. 6 B). To 
determine whether the increased level of neutrophils in the 
airways and that collected by BAL refl  ected a general increase 
in sequestration of cells in the lung by animals lacking the 
cotransporter, we measured myeloperoxidase (MPO) levels 
in whole lung homogenates (Fig. 6 C).  MPO is an enzyme 
primarily expressed by neutrophils and can be used as a sur-
rogate marker for quantitation of tissue neutrophil levels. 
Surprisingly, although there was a trend toward higher levels, 
the total lung MPO levels did not diff  er much between the 
NKCC1−/− and the control animals. This suggests that al-
though the overall number of neutrophils in the lungs was 
the same, the location of the neutrophils was altered in the 
absence of NKCC1, with cells moving into the airways and 
thus easily collected by lavage in the mutant animals. To fur-
ther examine this point, an additional group of NKCC1−/− 
mice and littermate controls were treated with LPS. 12 h 
later the animals were killed and the lungs were infl  ated, 
fi  xed in paraformaldehyde, embedded in plastic, and thin sec-
tions were prepared. The number of infl  ammatory cells pres-
ent in the airspaces in the two groups of animals was counted. 
Consistent with the increased neutrophil numbers in the 
BAL, a signifi  cantly higher number of neutrophils (P = 0.02) 
was observed in the alveolar spaces of the NKCC1−/− lungs 
compared with the control animals (Fig. 6, D and E). Similar 
to the studies of the K. pneumoniae–infected lungs, few diff  er-
ences were observed in the levels of cytokines present in the 
lungs of the wild-type and NKCC1−/− animals at this time 
point: no diff  erence was observed in the levels of TNF-α, 
keratinocyte chemoattractant, or macrophage infl  ammatory 
protein 2, although a small diff  erence was observed in IL-6 
levels (Fig. 7).
To further delineate the mechanism by which loss of 
NKCC1 alters the acute infl  ammatory response of mice to 
LPS, we examined this response in bone marrow chimeras in 
which loss of cotransporter expression was confi  ned to either 
the hematopoietic cells or to the parenchyma cells of the 
lung. Before initiating this line of experimentation, it was 
necessary to establish that lethal irradiation and reconstitution 
of mice with bone marrow did not itself alter the diff  erential 
response of the NKCC1−/− and wild-type mice to LPS. As 
can be seen in Fig. 8, and as expected, an increase in total cell 
numbers in the BAL was observed in the NKCC1−/− ani-
mals that were irradiated and reconstituted with NKCC1−/− 
marrow compared with similarly treated wild-type animals. 
With this established, we generated bone marrow chimeras. 
NKCC1−/− mice were irradiated and reconstituted with 
wild-type marrow. Conversely, wild-type mice were recon-
stituted with bone marrow cells harvested from NKCC1−/− 
mice. These two groups were treated with LPS, and the 
recruitment of leukocytes to the lung was evaluated. The in-
crease in infl  ux of leukocytes into alveolar spaces correlated 
with the genotype of the recipient animals: an increase in the 
cellularity of the BAL was observed in the NKCC1−/− mice 
which received wild-type bone marrow cells. This strongly 
Figure 5.  Assessment of bacterial load, cellular infi  ltrates, and 
edema formation after induction of peritonitis with K. pneumoniae 
in NKCC1− − and wild-type mice. (A) CFUs in the peritoneal lavage 
fl  uid of NKCC1+/+ and NKCC1−/− mice. Bacterial load was slightly lower 
in NKCC1−/− mice, but the reduced levels did not reach statistical sig-
nifi  cance (7–8 mice per group). (B) The total number of cells collected 
by peritoneal lavage was signifi  cantly decreased in NKCC1−/− mice 
compared with littermate controls (P = 0.04). (C) Differential cell counts 
were determined, based on morphological criteria, of cells present in the 
peritoneal lavage fl  uid of infected mice. A signifi  cant decrease was 
  observed in the number of peritoneal macrophages in NKCC1-defi  cient mice 
compared with wild-type controls (P = 0.016). Emigrated neutrophils were 
present 1 h after K. pneumoniae infection. However, NKCC1-defi  cient 
mice showed no compromise in neutrophil emigration compared with 
NKCC+/+ mice. (D) Consistent with a less robust infl  ammatory response, 
edema formation was signifi  cantly reduced in NKCC1−/− mice compared 
with littermate controls. Values are shown as mean ± SEM; n = 15–18 
mice per group. *, P < 0.05.1388  PROTECTION OF NKCC− − MICE FROM SEPSIS | Nguyen et al.
Figure 6.  Examination of the response of NKCC1−/− and control 
animals in a sterile model of acute lung infl  ammation. The total 
number of cells in the BALF was enumerated (A), and populations of 
leukocytes were determined based on morphological criteria (B). The 
total number of cells in the BAL was signifi  cantly increased in LPS-
 challenged  NKCC1−/− mice (P = 0.00007; n = 11) compared with the 
LPS-challenged NKCC1+/+ mice (n = 12). Differential cell counts showed 
that this increase was the result primarily of increased numbers of neutro-
phils (P = 0.0001) although a small but signifi  cant increase in the num-
ber of macrophages was also observed (P = 0.004) in NKCC1-defi  cient 
mice compared with wild-type controls. To determine whether this 
  difference represented a change in sequestration of neutrophils in the 
lung or specifi  cally the movement of the cells into the airway, lungs were 
harvested from similarly treated animals, and the level of MPO in the 
lung was determined (C). MPO levels in the lungs of NKCC1−/− mice 
(n = 11) were higher than in the wild-type controls (n = 12), but the 
increased levels did not reach statistical signifi  cance. To directly visualize 
differences in the location of infl  ammatory cells in the two mouse lines, 
lungs were fi  xed and sections were prepared from LPS and saline-treated 
animals 12 h after exposure. Images similar to those shown in E were 
scanned and analyzed using Image Scope viewing software, and cells 
present in the airways were enumerated in a blinded fashion. The number 
of neutrophils present in the airways of the NKCC1−/− lungs (n = 4) was 
higher than in the control animals (n = 4) (D). All values are expressed 
as mean ± SEM. *, P < 0.005 and **, P < 0.0005. Bars: (top) 50 μm; 
(bottom) 100 μm.JEM VOL. 204, June 11, 2007  1389
ARTICLE
indicates that loss of expression of NKCC1 on neutrophils 
is not responsible for the altered migration of the cells in 
response to LPS.
Attachment of neutrophils to activated endothelial cells is 
a prerequisite for recruitment during infl  ammatory responses. 
Activation of the endothelial cells results in expression of 
P and E selectins, which recognize L selectin expressed by 
neutrophils. Infl  ux of neutrophils into the airways correlates 
with increased expression of vascular cell adhesion molecule 
(VCAM)-1. To determine whether the increased numbers of 
neutrophils could refl  ect altered induction of VCAM on en-
dothelial cells, lungs were treated with LPS, and expression of 
VCAM was quantitated by Western blot analysis 6 h later 
(Fig. 9). As expected, LPS treatment results in an increase in 
levels of this protein. However, this change was observed in 
both NKCC1−/− and mutant mice and the magnitude of the 
change was similar in the two groups of animals.
Alterations in pulmonary vascular permeability in NKCC1−/− 
and wild-type mice after exposure to LPS
RNA expression analysis indicated that endothelial cells  ex-
press NKCC1 (Fig. 4). Expression was easily detected both on 
a mouse endothelial cell line and on primary endothelial cell 
cultures, which we prepared from the mouse lung. Endothelial 
cells play a critical role both in sequestration of leukocytes 
and regulation of the permeability barrier of the pulmonary 
vasculature. Given the increased traffi   cking of cells into the air-
way and similarity in total numbers of neutrophils, we expected 
that the NKCC1−/− mice would display a similar or increased 
change in vascular permeability in the lung compared with 
their controls. To address this question, mice were treated with 
LPS to induce an infl  ammatory response (Fig. 10). Serum pro-
teins were labeled by i.v. injection of animals with Evan’s blue. 
At various times after exposure to LPS, mice were killed, the 
pulmonary vascular system was flushed with PBS, and the 
amount of dye present in the tissue was determined. In all cases 
the level of dye observed in control animals treated with vehi-
cle was subtracted from the OD obtained from the LPS- treated 
animals. As expected, increased protein extravasation is ob-
served 3 h after exposure to LPS. Surprisingly, the amount of 
serum protein present in the NKCC1−/− lungs was signifi  -
cantly decreased compared with that observed in wild-type 
animals (Fig. 10 A). Even at 6 h, when the edema is beginning 
to resolve, the diff  erence between the two groups of animals 
persisted, suggesting that NKCC1 contributes to the changes 
in lung pulmonary vascular permeability during infl  ammation. 
To further address this point, we examined the lung wet to dry 
weight ratio of NKCC1−/− and control animals 3 h after in-
stillation of LPS. This ratio was signifi  cantly reduced in the 
NKCC1−/− animals (Fig. 10 B).
DISCUSSION
Previous studies of the role of NKCC1 in the pathophysiol-
ogy of infectious disorders have been limited for two reasons: 
(a) interpretation of traditional pharmacological studies using 
loop diuretics was diffi   cult because these drugs inhibit both 
NKCC1 and NKCC2: inhibition of NKCC1 leads to dra-
matic changes in blood volume with broad physiological con-
sequences; and (b) the use of mice lacking NKCC1 to address 
these questions has been complicated by the fact that survival 
and growth of these animals is compromised on inbred ge-
netic backgrounds. We have circumvented these problems by 
generating a coisogenic and congenic 129/SvEv and C57BL/6 
NKCC1-defi  cient mouse strain. Congenic F1 NKCC1−/− 
and control mice can then be generated by the intercross of 
these two lines. The survival of the 129B6F1 animals is greatly 
improved over that of C57BL/6 NKCC1−/− mice, and in 
addition, the size of the mice is within 10% of that of the wild-
type controls. The availability of genetically identical control 
and experimental animals is essential in the experiments 
reported here, where large diff  erences in the response of mice 
of various inbred backgrounds have been observed.
In our studies, we found that in the absence of NKCC1 
expression colonization of the lungs with K. pneumoniae was 
reduced approximately threefold. Absence of the cotrans-
porter had an even more dramatic eff  ect on the development 
of bacteremia and sepsis. Although wild-type mice became 
moribund during the course of the experiment and were re-
quired to be killed within 48 h of intratracheal inoculation, 
the majority of the NKCC1−/− mice remained surprisingly 
healthy and active throughout the duration of the experi-
ment. It is not clear at this point whether this dramatic dif-
ference in the development of hypothermic sepsis in the 
NKCC1−/− mice simply refl  ects the decreased bacterial bur-
den in the lungs or whether other aspects of NKCC1 func-
tion also contribute to bacterial dissemination from the lung 
into the bloodstream.
It is unlikely that expression of NKCC1 on cells of hema-
topoietic origin contributes to the decreased morbidity of the 
Figure 7.  Infl  ammatory mediator levels in the lung homogenates 
of LPS-challenged NKCC1+/+ and NKCC1−/− mice. No signifi  cant 
difference was observed in the levels of TNF-α, KC, and MIP-2 between 
NKCC1+/+ and NKCC1−/− mice. However, NKCC1−/− mice (P = 0.05) 
  exhibited slightly but signifi  cantly higher levels of IL-6 in comparison to 
littermate controls. Values are mean ± SEM from 11–12 mice per group. 
*, P < 0.05. conc., concentration.1390  PROTECTION OF NKCC− − MICE FROM SEPSIS | Nguyen et al.
NKCC1−/− mice. Levels of expression of NKCC1 detected 
by quantitative PCR are very low in neutrophils and macro-
phages. Consistent with this, no diff  erence was observed in 
the ability of NKCC1-defi  cient neutrophils to kill K. pneu-
moniae in vitro or in the induction of a respiratory burst in 
response to PMA stimulation. Additionally, the study of bone 
marrow chimeras lacking NKCC1 on cells of hematopoietic 
lineages showed normal recruitment and localization of 
NKCC1−/− neutrophils when the lung expressed NKCC1. 
Increased numbers of neutrophils were collected by BAL 
from both K. pneumoniae–infected NKCC1−/− mice and 
NKCC1−/− mice treated with LPS. This indicates that the 
number of neutrophils that had both left the circulation and 
moved through the endothelial and epithelial tight junctions 
was increased in these animals. In contrast, little diff  erence 
was seen in the number of neutrophils present in total lung 
homogenates from the LPS-challenged mice as determined 
by examination of myeloperoxidase levels. The most likely 
explanation for this is that change in expression of the co-
transporter alters the pattern of neutrophil traffi   cking in the 
lung. It is possible that increased access to the airways results 
in enhanced clearance of K. pneumoniae and hence the de-
creased bacterial load.
Figure 8.  Evaluation of the contribution of NKCC1 expression by 
hematopoietic and lung cells to LPS-elicited neutrophil recruitment. 
We fi  rst performed an experiment to determine whether a difference in 
neutrophil recruitment and localization would continue to be observed 
in mice exposed to lethal doses of irradiation. NKCC1−/− and NKCC1+/+ 
mice were lethally irradiated and reconstituted with genetically identical 
marrow (A). 6–8 wk after engraftment mice were challenged with LPS, the 
total cells in the BALF were enumerated, and the MPO content of the BAL 
and the lung was determined. As expected, we continued to observe an 
increase in the number of neutrophils present in the BAL, although no 
difference in the total number of cells recruited to the lung was apparent. 
To determine whether expression of NKCC1 by neutrophils contributes to 
the differential distribution of these cells, we generated a second cohort 
of mice. In this case, after irradiation, NKCC1−/− mice received marrow 
from wild-type animals (NKCC+/+® NKCC−/−), whereas NKCC1+/+ mice 
received marrow from NKCC1−/− mice (NKCC−/−® NKCC+/+) (B). Higher 
cell counts in the BALF and higher MPO levels in the cells collected by 
lavage corresponded with loss of NKCC1 expression in the recipient, not 
the donor marrow (NKCC+/+® NKCC−/−, n = 4). Cell counts and MPO 
activity were signifi  cantly higher in these animals compared with wild-
type animals in which the recipient expressed NKCC1 but was reconsti-
tuted with NKCC1−/− hematopoietic cells (NKCC−/−® NKCC+/+, n = 6). 
Again, no difference was observed between the groups in MPO activity 
in the lung. All values are expressed as mean ± SEM. *, P < 0.05.
Figure 9.  Western blot analysis of VCAM-1 after LPS stimulation. 
Lung lysates (100 μg of protein/lane) were subjected to Western blot 
analysis using polyclonal anti–mouse VCAM-1 antibody. GAPDH antibody 
was used as a loading control. Western blot analysis demonstrates an 
increase in VCAM-1 protein expression induced by LPS. However, the 
  increased levels did not differ between NKCC1+/+ and NKCC1−/− mice.
Figure 10.  Changes in the permeability of lung capillaries after 
exposure of mice to LPS. Evan’s blue extravasation was signifi  cantly 
lower in NKCC1−/− mice (n = 7) than in NKCC1+/+ mice (n = 6) both 
3 and 6 h after challenge. Similarly, a decrease in the wet-to-dry ratio 
was observed in the NKCC1−/− animals 3 h after LPS exposure (n = 25 
NKCC1+/+, n = 18 NKCC1−/−). Data are expressed as mean ± SEM. 
*, #, P< 0.05.JEM VOL. 204, June 11, 2007  1391
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NKCC1 is expressed by airway epithelial cells where it 
contributes to the formation of the airway surface liquid (30). 
NKCC1, located at the basolateral surface of the epithelium, 
works in tandem with cystic fi  brosis transmembrane conduc-
tance regulator and Ca2+-activated Cl− channels to transport 
Cl− across many secretory epithelia. In this regard it is in-
triguing that cystic fi  brosis patients, who also have a distur-
bance in Cl− secretion, have low incidence of sepsis despite 
high lung bacterial burdens. Staphylococcus aureus sepsis has 
not been described in CF patients, nor have invasive Pseudo-
monas infections been observed. One could speculate that the 
high levels of neutrophils in the CF lung also mimic what is 
observed in the NKCC1−/− mice. However, in the case of 
the CF patient, other factors and/or functions of CF render 
these recruited cells less eff  ective at clearing the bacteria than 
appears to be the case in the NKCC1−/− mouse. For exam-
ple, it has been suggested that CFTR directly regulates the 
activity of the epithelial sodium channel and thus that loss of 
CFTR results in Na+ hyperabsorption and dehydration of 
the airway surface of CF patients. These alterations would 
counteract the benefi  cial eff  ects of increased neutrophil re-
cruitment into alveolar spaces in a manner that does not 
compromise barrier function. This could provide an explana-
tion of why these patients, similar to the NKCC1−/− mice, 
appear protected from sepsis, but unlike the NKCC1−/− 
mice, have increased lung bacterial burdens.
The relatively high expression of NKCC1 on endothelial 
cells and the critical role of these cells in regulation of fl  uid fl  ux 
into lung tissues raises the possibility that this may represent 
the key cell type responsible for the increased survival of the 
NKCC1−/− mice with pneumonia. Fluid fl  ux into the alveo-
lar spaces is regulated by the lung capillary barrier and com-
promise of the integrity of this barrier leads to edema and 
intrapulmonary shunting. Altered endothelial function is the 
principal reason for failure of the barrier (31). It is interesting 
to speculate that increases in permeability of the barrier require 
contraction of the endothelial cell and a change in cell shape, 
and that these events are accompanied by a change in cell vol-
ume. It is possible that NKCC1 is required for these changes 
and when cells lack the cotransporter these changes are com-
promised. If this is the case, our failure to observe a decrease in 
edema formation in K. pneumoniae–induced peritonitis would 
suggest that this function of NKCC1 is critical only in some 
capillary beds. An alternative model is suggested by studies 
which have demonstrated a role for NKCC1 in vascular tone 
(32). It is possible that decreased vascular pressure decreases 
edema formation in the lung. Again, in this model the contri-
bution of NKCC1 to venous tone would be limited to specifi  c 
vascular beds. The development of mouse lines in which loss 
of expression of NKCC1 is limited to specifi  c tissues should 
help to distinguish between these various models.
In summary, we show here that loss of NKCC1 expres-
sion dramatically alters the course of bacterial pneumonia. 
Importantly, mice lacking the NKCC1 cotransporter were 
protected from sepsis and bacteremia. The impact of loss of 
NKCC1 was observed primarily in the lung. In contrast, the 
NKCC1−/− mice tended toward more severe disease when 
K. pneumoniae was introduced into the peritoneal cavity. 
Collectively, our results suggest that inhibitors specifi  c for 
NKCC1 might provide a novel means of limiting sepsis in 
individuals with bacterial pneumonia. Given the profound 
impact of loss of NKCC1 on disease progression, it will be 
of great interest to more precisely defi  ne the mechanism 
underlying the attenuation of disease upon loss of NKCC1 
activity. This should be possible with the development of 
culture conditions that allow in vitro study of endothelial 
barrier function of cells prepared from NKCC1−/− and con-
trol animals, and the generation of mouse lines in which the 
loss of expression of NKCC1 can be regulated in a cell type–
specifi  c manner.
MATERIALS AND METHODS
Animals. Mice were bred and maintained in pathogen-free animal facilities 
at the University of North Carolina at Chapel Hill in accordance with 
the Institutional Animal Care and Use Committee. The generation of 
NKCC1−/− mice has been described (25). F1 NKCC1-defi  cient and wild-
type control mice were generated by crossing C57BL/6 congenic NKCC+/− 
mice (N12) to 129/SvEv+/− coisogenic mice.
Bacteria. Mouse virulent strain K. pneumoniae 43816, serotype 2, from the 
American Type Culture Collection were aerobically grown in nutrient 
broth for 2 h at 37°C. Bacteria numbers were estimated by measuring the 
absorbance at 600 nm (1 OD = 3 × 108 bacteria/ml) and exact number used 
in each experiment determining CFUs after plating an aliquot onto a nutri-
ent agar plate.
K. pneumoniae–induced lung infl  ammation. Mice were anesthetized, 
placed in an upright position, and suspended by the incisors over a supporting 
wire. The tongue was extended, and 4 × 104 CFU of K. pneumoniae in 50 μl 
PBS was delivered onto the vocal cords.
Assessment of lung infl  ammatory cells. 48 h postinfection with K. pneu-
moniae and 6 h after LPS challenge, the lungs were lavaged fi  ve times 
with Hanks’ balance salt solution. The recovered BALF was pooled, and 
a 50-μl aliquot was reserved for determination of total cell counts with 
a hemacytometer. For diff  erential cell counts, cytospin slides were pre-
pared, stained using a Hema-3 staining kit (Fisher Scientifi  c), and >200 
leukocytes were identifi  ed based on morphological criteria per slide from 
each sample.
Assessment of K. pneumoniae in blood and lung tissues. 48 h postinfection 
with K. pneumoniae, mice were anesthetized and blood samples were ob-
tained by cardiac puncture. Lungs were removed after pulmonary perfusion 
with PBS/5 mM EDTA and homogenized in a glass grinder with 2 ml of 
homogenate buff  er (PBS with 1% Triton X-100) containing protease inhibi-
tor tablet (Roche Diagnostics). Aliquots of the suspensions were plated onto 
LP plates, and CFUs were determined.
Cytokine and chemokine analysis postinfl  ammation. After centrifuga-
tion of lung homogenates, supernatants were passed through a 0.45-μm 
  syringe-driven fi  lter unit to remove bacteria. TNF-α, IL-1β, IL-10, KC, and 
MIP-2 levels in supernatants and in BALF were determined by commercial 
ELISA kits (R&D Systems) according to the manufacturer’s instructions.
Preparation of specifi  c immune serum and opsonization of bacteria. 
Specifi  c immune serum was prepared as described previously (33). Bacteria 
(107) were suspended in 1 ml of HBSS containing 1 mM CaCl2, 0.5 mM 
MgCl2 and 1 mM Hepes with 5% specifi  c immune serum for 15 min at 37°C 
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Preparation of neutrophils and neutrophil-killing assays. Bone mar-
row was collected from mouse femurs and tibias, and neutrophils were iso-
lated by density gradient centrifugation through 2 Histopaque layers (density 
1.083 g/ml and 1.119 g/L; Sigma-Alrich). Preparations were > 90% pure as 
determined by staining with the Hema-3 staining kit (Fisher Scientifi  c) and 
examination of cell morphology. Assessment of bacterial killing by neutro-
phils was performed as previously described (34, 35).
Measurement of superoxide production. Superoxide production was 
monitored by measurement of the superoxide dismutase–inhibitable cyto-
chrome C reduction in a modifi  cation of methods described by Pick and 
Mizel (36). Superoxide produced by neutrophils was calculated from the ex-
tinction coeffi   cient of cytochrome C by the formula ∆E550 = 2103 M−1cm−1. 
The results were expressed as nanomoles of reduced cytochrome C.
LPS-induced lung infl  ammation. Anesthetized mice received 0.3 mg/kg 
of LPS (from Escherichia coli, Sigma-Aldrich) in 50 μl PBS intratracheally. 6 h 
later, mice were killed and harvested for assessment of airway infl  ammatory 
cells, mediator levels, and MPO activity.
MPO assay. MPO activity in lung tissues was measured 6 h after LPS 
exposure as described previously (37–41). MPO activity was quantifi  ed by 
extrapolation from the standard curve.
Lung permeability assay. Lung capillary permeability was determined by 
Evan’s blue dye extravasation (42). 5 h after intratracheal challenge with LPS 
(1 mg/kg), mice received 10 mg/ml solution of Evan’s blue dye i.v. (100 
mg/kg). 1 h later, mice were killed and lungs were harvested after perfusion 
with HBSS and incubated in 2 ml of formamide at 55°C for 48 h. The ab-
sorbance of the Evan’s blue extracts was spectrophotometrically measured at 
620 and 740 nm. The following formula was used to correct for the presence 
of heme pigments: A620 (corrected) = (1.426 × A740 + 0.030).
Lung wet-to-dry weight ratio measurement. Mice were treated with 
LPS and 3 h later killed and whole lungs were excised and blotted dry and 
weighed. Lung dry weights were recorded after lung samples were dried in 
the oven for 3 d at 65°C. The lung wet-to-dry weight ratio was calculated 
by dividing the wet weight by the dry weight.
Isolation of pulmonary endothelial cells. Endothelial cells were isolated 
by magnetic cell sorting of labeled endothelial cells using a MACS separation 
unit (Miltenyi Biotec) as described previously by Marelli-Berg et al. (43). 
Endothelial cells were plated out onto 1% gelatin- (type B from bovine) 
coated tissue culture plates and cultured until confl  uent. At confl  uence, 
endothelial cells were characterized and RNA was prepared.
Quantitative RT-PCR. Total RNA was isolated using RNazol B (Teltest). 
Reverse transcription of RNA to cDNA for quantitative RT-PCR was 
performed using a high-capacity cDNA archive kit (Applied Biosystems) ac-
cording to the manufacturer’s instructions. Primers and probes were pur-
chased from Applied Biosystems. All reactions were performed with TaqMan 
PCR Universal Master Mix (Applied Biosystems) using the Applied Bio-
systems 7900 HT Fast Real-Time PCR System. Reactions were performed 
in quadruplicate in a 20 μl fi  nal volume reaction. Expression levels of genes 
of interest were normalized to 18S RNA. Data were analyzed using the 
comparative CT method as described by Applied Biosystems.
Lung histology. Mice received 0.3 mg/kg of LPS or vehicle intratraceally 
as described above. Mice were killed 12 h later and lungs were infl  ated, re-
moved, and fi  xed in 2% paraformaldehyde/4% glutaraldehyde in Karlsson 
and Schultz sodium phosphate buff  er at 4°C overnight. The left lobes were 
processed and embedded in paraffi   n wax. 4-μm-thick sections were cut and 
stained with hematoxylin and eosin. The other lobes were diced into small 
pieces and fi  xed again in glutaraldehyde fi  xative for 24 h. Subsequently, lung 
samples were postfi  xed in 1% osmium tetroxide, dehydrated in a graded 
ethanol series, and Epon infi  ltrated in an automated Reichert Lynx EM tis-
sue processor. Specimens were embedded in Epon 812 and polymerized 
overnight at 65°C. 0.5-μm-thick sections were cut and stained with 1% To-
luidine blue-O in 1% sodium borate. Slides were scanned with an Aperio 
ScanScope scanner (Aperio Technologies, Inc.) at 20× power to produce a 
high resolution digital image. Digital images were then analyzed using Image-
Scope viewing software (Aperio Technologies, Inc.), and neutrophils were 
counted in a blinded fashion.
K. pneumoniae–induced peritoneal infl  ammation. Mice received 0.5% 
Evan’s blue dye (Sigma-Aldrich) i.v. (10 mg/kg) followed by i.p injection of 106 
CFU K. pneumoniae. 1 h after infection, mice were killed and the peritoneal 
cavities were lavaged with 4 ml of cold PBS. The number of peritoneal exu-
date cells in the peritoneal lavage fl  uid was determined by cell counts using a 
hemacytometer, and cellular diff  erential were performed on cytospun slides. 
CFUs were determined after 18 h of incubation at room temperature on agar 
plates. Plasma protein extravasation into the peritoneal cavity was determined 
by measuring the absorbance of Evan’s blue dye in the cell-free supernatants.
Western blotting. Lung lysates were prepared in lysis buff  er. Samples (100 μg) 
were electrophoresed on 10% SDS-PAGE gels, and the proteins were 
electrophoretically transferred to PVDF membrane. Membranes were 
blocked in 5% nonfat milk in TBS with 0.1% Tween 20 for 1 h at room 
temperature and incubated overnight at 4°C with polyclonal anti–mouse 
VCAM-1 (R & D Systems, Inc.) at a fi  nal concentration of 0.1 μg/ml. 
Horseradish peroxidase–conjugated goat anti–mouse immunoglobulin G 
(Santa Cruz Biotechnology) was used as an appropriate secondary antibody. 
The blot was stripped and reprobed with anti-GAPDH (Imgenex) at a 
1:5,000 dilution.
Generation of chimeric mice. Chimeric mice were generated using a 
previously described bone marrow transplantation method with modifi  ca-
tions (44). In brief, whole bone marrow cells were harvested from femurs 
and tibias of 8-wk-old donor mice. Bone marrow cells were washed once, 
fi  ltered through Miracloth (Calbiochem), and resuspended in PBS. Recipi-
ent mice were lethally irradiated with two exposures to 5 Gy 3 h apart. Im-
mediately after the second exposure of irradiation, donor bone marrow cells 
were injected i.v into lethally irradiated recipient mice. Chimeric animals 
were used 6–8 wk after bone marrow transplantation.
Statistical analysis. Data are presented as mean ± SEM. Statistical com-
parisons between groups of mice were made by two-tailed Student’s t-test. 
P < 0.05 was considered statistically signifi  cant.
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